Standard
Myelotoxicity Following High-Dose Methotrexate in Children with Down Syndrome and Acute Lymphoblastic Leukemia. / Bohnstedt, C.; Levinsen, M.; Rosthøj, S.; Zeller, B.; Taskinen, M.; Hafsteinsdottir, S.; Bjorgvinsdottir, H.; Heymann, M.; Schmiegelow, K.
I:
Medical and Pediatric Oncology. Supplement, Bind 65, 2018, s. S104.
Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › fagfællebedømt
Harvard
Bohnstedt, C, Levinsen, M
, Rosthøj, S, Zeller, B, Taskinen, M, Hafsteinsdottir, S, Bjorgvinsdottir, H, Heymann, M
& Schmiegelow, K 2018, '
Myelotoxicity Following High-Dose Methotrexate in Children with Down Syndrome and Acute Lymphoblastic Leukemia',
Medical and Pediatric Oncology. Supplement, bind 65, s. S104.
https://doi.org/10.1002/pbc.27455APA
Bohnstedt, C., Levinsen, M.
, Rosthøj, S., Zeller, B., Taskinen, M., Hafsteinsdottir, S., Bjorgvinsdottir, H., Heymann, M.
, & Schmiegelow, K. (2018).
Myelotoxicity Following High-Dose Methotrexate in Children with Down Syndrome and Acute Lymphoblastic Leukemia.
Medical and Pediatric Oncology. Supplement,
65, S104.
https://doi.org/10.1002/pbc.27455Vancouver
Bohnstedt C, Levinsen M
, Rosthøj S, Zeller B, Taskinen M, Hafsteinsdottir S o.a.
Myelotoxicity Following High-Dose Methotrexate in Children with Down Syndrome and Acute Lymphoblastic Leukemia.
Medical and Pediatric Oncology. Supplement. 2018;65:S104.
https://doi.org/10.1002/pbc.27455Author
Bohnstedt, C. ; Levinsen, M. ; Rosthøj, S. ; Zeller, B. ; Taskinen, M. ; Hafsteinsdottir, S. ; Bjorgvinsdottir, H. ; Heymann, M. ; Schmiegelow, K. / Myelotoxicity Following High-Dose Methotrexate in Children with Down Syndrome and Acute Lymphoblastic Leukemia. I: Medical and Pediatric Oncology. Supplement. 2018 ; Bind 65. s. S104.
Bibtex
@article{6475af36738b448b957a15e12470f896,
title = "Myelotoxicity Following High-Dose Methotrexate in Children with Down Syndrome and Acute Lymphoblastic Leukemia",
author = "C. Bohnstedt and M. Levinsen and S. Rosth{\o}j and B. Zeller and M. Taskinen and S. Hafsteinsdottir and H. Bjorgvinsdottir and M. Heymann and K. Schmiegelow",
note = "Abstract PO-020",
year = "2018",
doi = "10.1002/pbc.27455",
language = "English",
volume = "65",
pages = "S104",
journal = "Medical and Pediatric Oncology. Supplement",
issn = "0740-8226",
publisher = "JohnWiley & Sons, Inc.",
}
RIS
TY - ABST
T1 - Myelotoxicity Following High-Dose Methotrexate in Children with Down Syndrome and Acute Lymphoblastic Leukemia
AU - Bohnstedt, C.
AU - Levinsen, M.
AU - Rosthøj, S.
AU - Zeller, B.
AU - Taskinen, M.
AU - Hafsteinsdottir, S.
AU - Bjorgvinsdottir, H.
AU - Heymann, M.
AU - Schmiegelow, K.
N1 - Abstract PO-020
PY - 2018
Y1 - 2018
U2 - 10.1002/pbc.27455
DO - 10.1002/pbc.27455
M3 - Conference abstract in journal
C2 - 30240102
VL - 65
SP - S104
JO - Medical and Pediatric Oncology. Supplement
JF - Medical and Pediatric Oncology. Supplement
SN - 0740-8226
ER -
